OraSure Technologies | OSUR - Gross Profit On Sales

Stock Price
3.21
Daily Change
0.002 0.06%
Monthly
2.62%
Yearly
10.00%
Q2 Forecast
2.88

OraSure Technologies reported $11.34M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Agilent USD 946M 44M Dec/2025
AngioDynamics USD 44.78M 2.93M Sep/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Bio Techne USD 191.28M 3.16M Dec/2025
Bio-Rad Laboratories USD 343.4M 1.9M Sep/2025
Bruker USD 449.2M 69.8M Dec/2025
Cerus USD 33.33M 8.66M Dec/2024
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Danaher USD 3.97B 443M Dec/2025
Dentsply International USD 443M 2M Dec/2025
Dexcom USD 792.7M 61.3M Dec/2025
Illumina USD 759M 26M Dec/2025
Integra LifeSciences USD 217.1M 10.11M Dec/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Quidel USD 274.8M 1.01B Dec/2025
Repligen USD 103.83M 3.32M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
STAAR Surgical USD 43.74M 34.13M Dec/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Trinity Biotech USD 6.47M 1.59M Sep/2025
Waters USD 557.42M 97.44M Dec/2025